Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	question first answered
creator	label
publisher	pref label
tabling member	label

Search

179004

	human indexable
	published
	registered interest
	answer date	23/02/2015
	date	10/02/2015
	date tabled	10/02/2015
	ddp created	11/02/2015 00:23:16
	ddp modified	23/02/2015 16:37:09
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	1
	identifier	224080
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	23/02/2015 16:05:17
	question text	To ask the Secretary of State for Health, with reference to Part 5 (a) (ii) of the Mitochndrial Donation Regulations 2015, how the Human Fertilisation and Embryology Authority plans to define a "significant risk" of having or developing serious mitochondrial disease.
	session	2014/15
	session number	4
	tabling member constituency	Stoke-on-Trent South
	tabling member printed	Robert Flello
	title	House of Commons Tabled Parliamentary Question 2014/15 224080
	type	WrittenParliamentaryQuestion
	uin	224080
	version	1
	written parliamentary question type	NamedDay
	answer	answer question first answered 23/02/2015 16:05:17
	creator	1569 label Biography information for Robert Flello
	publisher	25259 pref label House of Commons
	tabling member	1569 label Biography information for Robert Flello

178544

	human indexable
	published
	registered interest
	answer date	12/02/2015
	date	09/02/2015
	date tabled	09/02/2015
	ddp created	09/02/2015 21:43:48
	ddp modified	12/02/2015 17:52:06
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	1
	identifier	223866
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	12/02/2015 17:20:11
	question text	To ask the Secretary of State for Health, what estimate he has made of the cost to the public purse of (a) treatments for mitochondrial disease involving mitochondrial donation and (b) treatments for mitochondrial disease that do not involve mitochondrial donation in each of the next five financial years.
	session	2014/15
	session number	4
	tabling member constituency	North Tyneside
	tabling member printed	Mrs Mary Glindon
	title	House of Commons Tabled Parliamentary Question 2014/15 223866
	type	WrittenParliamentaryQuestion
	uin	223866
	version	1
	written parliamentary question type	NamedDay
	answer	answer question first answered 12/02/2015 17:20:11
	creator	4126 label Biography information for Mary Glindon
	publisher	25259 pref label House of Commons
	tabling member	4126 label Biography information for Mary Glindon

223632

	human indexable
	published
	registered interest
	answer date	27/02/2015
	date	25/02/2015
	date tabled	25/02/2015
	ddp created	25/02/2015 22:58:37
	ddp modified	03/03/2015 11:09:04
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	1
	identifier	225464
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	03/03/2015 10:37:42
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the health effects of consanguineous marriages; and what steps he is taking to reduce them.
	session	2014/15
	session number	4
	tabling member constituency	Shipley
	tabling member printed	Philip Davies
	title	House of Commons Tabled Parliamentary Question 2014/15 225464
	type	WrittenParliamentaryQuestion
	uin	225464
	version	2
	written parliamentary question type	Ordinary
	answer	answer question first answered 03/03/2015 10:37:42
	creator	1565 label Biography information for Sir Philip Davies
	publisher	25259 pref label House of Commons
	tabling member	1565 label Biography information for Sir Philip Davies

224726

	human indexable
	published
	registered interest
	answer date	05/03/2015
	date	03/03/2015
	date tabled	03/03/2015
	ddp created	03/03/2015 23:12:47
	ddp modified	10/03/2015 17:55:03
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	1
	identifier	226013
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	10/03/2015 17:23:17
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 3 March 2015 to Question 225464, if he will estimate the annual cost to the NHS of the implications of genetic inheritance birth defects.
	session	2014/15
	session number	4
	tabling member constituency	Shipley
	tabling member printed	Philip Davies
	title	House of Commons Tabled Parliamentary Question 2014/15 226013
	type	WrittenParliamentaryQuestion
	uin	226013
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 10/03/2015 17:23:17
	creator	1565 label Biography information for Sir Philip Davies
	publisher	25259 pref label House of Commons
	tabling member	1565 label Biography information for Sir Philip Davies

228709

	human indexable
	published
	registered interest
	answer date	30/03/2015
	date	19/03/2015
	date tabled	19/03/2015
	ddp created	19/03/2015 22:18:55
	ddp modified	25/03/2015 22:02:56
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	2
	identifier	HL5891
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	25/03/2015 14:05:28
	question text	To ask Her Majesty’s Government which organisation or body is responsible for assessing the needs of the local population for carrier screening for genetic disorders in at risk populations without an established family history.
	session	2014/15
	session number	4
	tabling member printed	Baroness Deech
	title	House of Lords Tabled Parliamentary Question 2014/15 HL5891
	type	WrittenParliamentaryQuestion
	uin	HL5891
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 25/03/2015 14:05:28
	creator	3756 label Biography information for Baroness Deech
	publisher	25277 pref label House of Lords
	tabling member	3756 label Biography information for Baroness Deech

228712

	human indexable
	published
	registered interest
	answer date	30/03/2015
	date	19/03/2015
	date tabled	19/03/2015
	ddp created	19/03/2015 22:18:57
	ddp modified	25/03/2015 22:02:59
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	2
	identifier	HL5894
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	25/03/2015 14:05:28
	question text	To ask Her Majesty’s Government which government department, NHS organisation or body is currently responsible for commissioning carrier screening services for (1) Tay Sachs disease, (2) Familial Dysautonomia and Canavan disease, and (3) other severe inherited genetic disorders, in at risk populations without an established family history.
	session	2014/15
	session number	4
	tabling member printed	Baroness Deech
	title	House of Lords Tabled Parliamentary Question 2014/15 HL5894
	type	WrittenParliamentaryQuestion
	uin	HL5894
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 25/03/2015 14:05:28
	creator	3756 label Biography information for Baroness Deech
	publisher	25277 pref label House of Lords
	tabling member	3756 label Biography information for Baroness Deech

228711

	human indexable
	published
	registered interest
	answer date	30/03/2015
	date	19/03/2015
	date tabled	19/03/2015
	ddp created	19/03/2015 22:18:56
	ddp modified	25/03/2015 22:02:58
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	2
	identifier	HL5893
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	25/03/2015 14:05:28
	question text	To ask Her Majesty’s Government which government department or organisation or body in the National Health Service is currently responsible for setting or determining the national policy for carrier screening for (1) Tay Sachs disease, (2) Familial Dysautonomia and Canavan disease, and (3) other severe inherited genetic disorders, in at risk populations without an established family history.
	session	2014/15
	session number	4
	tabling member printed	Baroness Deech
	title	House of Lords Tabled Parliamentary Question 2014/15 HL5893
	type	WrittenParliamentaryQuestion
	uin	HL5893
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 25/03/2015 14:05:28
	creator	3756 label Biography information for Baroness Deech
	publisher	25277 pref label House of Lords
	tabling member	3756 label Biography information for Baroness Deech